EDGAR Filing Documents for 0001193125-23-276182

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-23-276182

Filing Date

2023-11-13

Accepted

2023-11-13 17:08:12

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d576437ds3.htm	S-3	305653
2	EX-4.3	d576437dex43.htm	EX-4.3	279798
3	EX-4.6	d576437dex46.htm	EX-4.6	93165
4	EX-4.7	d576437dex47.htm	EX-4.7	94950
5	EX-4.8	d576437dex48.htm	EX-4.8	82875
6	EX-5.1	d576437dex51.htm	EX-5.1	25166
7	EX-23.1	d576437dex231.htm	EX-23.1	1581
8	EX-FILING FEES	d576437dexfilingfees.htm	EX-FILING FEES	29391
9	GRAPHIC	g576437g00a03.jpg	GRAPHIC	36066
10	GRAPHIC	g576437g1111005917735.jpg	GRAPHIC	2534
	Complete submission text file	0001193125-23-276182.txt		963252

Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612

Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280

Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)